Reported 454,619 shares, up 132,925 (41.3%) from the prior quarter.
Reported value 77.1%; share count 41.3% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2023-06-30 | 672125 |
| 2023-09-30 | 1187453 |
| 2023-12-31 | 1458616 |
| 2024-03-31 | 1639214 |
| 2024-06-30 | 930080 |
| 2024-09-30 | 1233667 |
| 2024-12-31 | 1204533 |
| 2025-03-31 | 1981635 |
| 2025-06-30 | 3509658 |
| 2025-09-30 | 5184017 |
| 2025-12-31 | 3955331 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q4 2025 | Added | 496,901 | +23,042 (4.9%) | < 0.01% | $3,955,331 | 2026-01-29 | |
| Q3 2025 | Added | 473,859 | +19,240 (4.2%) | < 0.01% | $5,184,017 | 2025-11-07 | |
| Q2 2025 | Added | 454,619 | +132,925 (41.3%) | < 0.01% | $3,509,658 | 2025-08-11 | |
| Q1 2025 | Added | 321,694 | +75,871 (30.9%) | < 0.01% | $1,981,635 | 2025-05-09 | |
| Q4 2024 | Added | 245,823 | +561 (0.2%) | < 0.01% | $1,204,533 | 2025-02-11 | |
| Q3 2024 | Added | 245,262 | +18,965 (8.4%) | < 0.01% | $1,233,667 | 2024-11-13 | |
| Q2 2024 | Added | 226,297 | +10,611 (4.9%) | < 0.01% | $930,080 | 2024-08-13 | |
| Q1 2024 | Added | 215,686 | +40,792 (23.3%) | < 0.01% | $1,639,214 | 2024-05-10 | |
| Q4 2023 | Added | 174,894 | +34,367 (24.5%) | < 0.01% | $1,458,616 | 2024-02-14 | |
| Q3 2023 | Added | 140,527 | +69,777 (98.6%) | < 0.01% | $1,187,453 | 2023-11-14 | |
| Q2 2023 | New | 70,750 | +70,750 (0.0%) | < 0.01% | $672,125 | 2023-08-14 |
Who else reported the position
28 managers reported ELICIO THERAPEUTICS INC for Q2 2025.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| Knoll Capital Management LLC | Unchanged | 630,915 | 0 | 3.46% | $4,870,663 | 2 qtrs |
| VANGUARD GROUP INC This report | Added | 454,619 | +132,925 | < 0.01% | $3,509,658 | 9 qtrs |
| GEODE CAPITAL MANAGEMENT LLC | Added | 120,831 | +43,364 | < 0.01% | $932,876 | 9 qtrs |
| NORTHERN TRUST CORPORATION | Reduced | 51,000 | -855 | < 0.01% | $393,720 | 5 qtrs |
| BlackRock Inc | Added | 43,557 | +4,234 | < 0.01% | $336,260 | 4 qtrs |
| CM Management LLC | Reduced | 25,000 | -30,000 | 0.18% | $193,000 | 9 qtrs |
| STATE STREET CORPORATION | Unchanged | 21,600 | 0 | < 0.01% | $166,752 | 6 qtrs |
| Quantinno Capital Management LP | Unchanged | 20,000 | 0 | < 0.01% | $154,400 | 2 qtrs |
| SUSQUEHANNA INTERNATIONAL GROUP LLP | Reduced | 17,023 | -14,338 | < 0.01% | $131,418 | 2 qtrs |
| MEYER HANDELMAN CO | Unchanged | 13,899 | 0 | < 0.01% | $107,300 | 9 qtrs |
Filing details and methodology As reported
- Report period
- June 30, 2025
- Filed
- August 11, 2025
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 0
- Shared
- 0
- None
- 454,619
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.